Haleon PLC Sponsored ADR (HLN)
NYSE:HLN
HLN Stock Chart & Stats
$9.52
$0.04(0.37%)
At close: 4:00 PM EST
$9.52
$0.04(0.37%)
Day’s Range― - ―
52-Week Range$8.71 - $11.42
Previous CloseN/A
Volume6.87M
Average Volume (3M)8.96M
Market Cap
$43.49B
Enterprise Value$39.76B
Total Cash (Recent Filing)$1.32B
Total Debt (Recent Filing)$8.59B
Price to Earnings (P/E)20.6
Beta0.16
Next Earnings
Jul 30, 2026EPS Estimate
0.28Next Dividend Ex-DateN/A
Dividend Yield1.74%
Share Statistics
EPS (TTM)0.13
Shares Outstanding4,464,590,000
10 Day Avg. Volume9,588,668
30 Day Avg. Volume8,958,272
Financial Highlights & Ratios
PEG Ratio1.65
Price to Book (P/B)2.05
Price to Sales (P/S)3.12
P/FCF Ratio17.06
Enterprise Value/Market Cap0.91
Enterprise Value/Revenue3.62
Enterprise Value/Gross Profit5.58
Enterprise Value/Ebitda14.07
Forecast
1Y Price Target
$13.92Price Target Upside46.22% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.55
Revenue Forecast (FY)$15.28B
Bulls Say, Bears Say
Bulls Say
Improving Margins & Cash GenerationSustained margin expansion and very high free cash flow conversion point to durable earnings quality. Strong gross/net margins enable investment in A&P and R&D, fund the dividend and debt paydown, and provide flexibility to fund growth or weather volume slippage without immediate capital strain.
Leading Oral Health BrandsCategory leadership in Oral Health with brands like Sensodyne drives repeat purchases, pricing power and stable volume share. Durable brand equity in a staples category supports resilient revenue streams, a higher margin mix, and a reliable platform for reinvestment and cross‑sell over the medium term.
E‑commerce And Channel CapabilitiesEstablished e‑commerce share and superior online brand positioning align with secular channel shift to digital. Strong online reach improves margin control, consumer data access and marketing ROI, making growth less dependent on traditional retail shelf space and more resilient over multi‑year horizons.
Bears Say
Soft Revenue And Low VolumesPersistently weak volume trends constrain sustainable top‑line growth and increase reliance on margin recovery and pricing. With average volume well below peer targets, long‑term growth will need sustained share gains, new product success or structural category improvements to reduce dependence on one‑off productivity.
Meaningful Absolute Debt LoadA sizable debt stock reduces strategic optionality and heightens refinancing and interest risks if growth softens. Debt constrains capital allocation—limiting M&A, incremental marketing or R&D—and makes the company more vulnerable to macro shocks despite improving leverage ratios.
U.S. & Pharmacy Channel HeadwindsThe U.S. pharmacy channel is strategically important; sustained retailer destocking and uncertain ownership dynamics can materially depress sell‑through and distribution cadence. Structural channel disruption increases revenue volatility and complicates execution of medium‑term growth plans.
Haleon PLC Sponsored ADR News
HLN FAQ
What was Haleon PLC Sponsored ADR’s price range in the past 12 months?
Haleon PLC Sponsored ADR lowest stock price was $8.71 and its highest was $11.42 in the past 12 months.
What is Haleon PLC Sponsored ADR’s market cap?
Haleon PLC Sponsored ADR’s market cap is $43.49B.
When is Haleon PLC Sponsored ADR’s upcoming earnings report date?
Haleon PLC Sponsored ADR’s upcoming earnings report date is Jul 30, 2026 which is in 125 days.
How were Haleon PLC Sponsored ADR’s earnings last quarter?
Haleon PLC Sponsored ADR released its earnings results on Feb 25, 2026. The company reported $0.129 earnings per share for the quarter, beating the consensus estimate of $0.124 by $0.005.
Is Haleon PLC Sponsored ADR overvalued?
According to Wall Street analysts Haleon PLC Sponsored ADR’s price is currently Undervalued.
Does Haleon PLC Sponsored ADR pay dividends?
Haleon PLC Sponsored ADR pays a Quarterly dividend of $0.059 which represents an annual dividend yield of 1.74%. See more information on Haleon PLC Sponsored ADR dividends here
What is Haleon PLC Sponsored ADR’s EPS estimate?
Haleon PLC Sponsored ADR’s EPS estimate is 0.28.
How many shares outstanding does Haleon PLC Sponsored ADR have?
Haleon PLC Sponsored ADR has 4,464,590,000 shares outstanding.
What happened to Haleon PLC Sponsored ADR’s price movement after its last earnings report?
Haleon PLC Sponsored ADR reported an EPS of $0.129 in its last earnings report, beating expectations of $0.124. Following the earnings report the stock price went down -5.776%.
Which hedge fund is a major shareholder of Haleon PLC Sponsored ADR?
Currently, no hedge funds are holding shares in HLN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Haleon PLC Sponsored ADR Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$13.92 (46.22% Upside)
$13.92 (46.22% Upside)
Blogger Sentiment
Neutral
HLN Sentiment 50%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 2.4M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.9%
Last 30 Days ▲ 10.8%
Last 30 Days ▲ 10.8%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-1.22%
12-Months-Change
Fundamentals
Return on Equity
9.44%
Trailing 12-Months
Asset Growth
2.12%
Trailing 12-Months
Company Description
Haleon PLC Sponsored ADR
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.
HLN Company Deck
HLN Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call balances clear operational and strategic progress (notably strong margin/cost improvements, Oral Health outperformance, emerging markets growth, increased A&P/R&D investment, and a planned $175–$200M cost saving reorganization) against meaningful top-line and volume challenges (soft U.S. market, cold & flu season weakness, category-specific headwinds, and regional retailer/inventory issues). Management presented realistic 2026 guidance (3%–5%) while reiterating confidence in returning to the 4%–6% medium-term ambition as U.S. performance, distribution gains, and productivity benefits materialize.View all HLN earnings summariesHLN Stock 12 Month Forecast
Average Price Target
$13.92
▲(46.22% Upside)
Technical Analysis
Dr Reddy's Laboratories
―
Viatris
―
Perrigo Company
―
Teva Pharmaceutical
―
Takeda Pharmaceutical Company
―
Ownership Overview
―
Insiders
4.34% Mutual Funds
5.90% Other Institutional Investors
89.56% Public Companies and
Individual Investors